Yoshida R, Zawadzki Z A
Oncology. 1980;37(3):152-6. doi: 10.1159/000225425.
A group of 100 patients with various neoplastic disorders and 25 healty subjects were studied by the 125I-Clq and 125I-mRF inhibition tests for the presence of circulating immune complexes in the sera. The presence of circulating immune complexes was detected in 32 and 23% of the 100 patients by the 125I-Clq inhibition test and 125I-mRF inhibition test, respectively. A discrepancy between the two radioimmunoassays in cancer sera may suggest a possibility of the occurrence of quantatively different types of circulating immune complexes in neoplastic disorders.
通过125I-Clq和125I-mRF抑制试验，对100例患有各种肿瘤疾病的患者和25名健康受试者的血清进行循环免疫复合物检测。在100例患者中，分别有32%和23%的患者通过125I-Clq抑制试验和125I-mRF抑制试验检测到循环免疫复合物的存在。癌症患者血清中两种放射免疫测定结果之间的差异可能提示在肿瘤疾病中存在定量不同类型的循环免疫复合物的可能性。
